NCT06756646

Brief Summary

Investigate the effects of exercise training on the cardiopulmonary function and exercise capacity in COPD patients.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable chronic-obstructive-pulmonary-disease

Timeline
56mo left

Started Nov 2024

Longer than P75 for not_applicable chronic-obstructive-pulmonary-disease

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress24%
Nov 2024Dec 2030

Study Start

First participant enrolled

November 20, 2024

Completed
29 days until next milestone

First Submitted

Initial submission to the registry

December 19, 2024

Completed
15 days until next milestone

First Posted

Study publicly available on registry

January 3, 2025

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2028

Expected
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2030

Last Updated

January 3, 2025

Status Verified

December 1, 2024

Enrollment Period

4.1 years

First QC Date

December 19, 2024

Last Update Submit

December 25, 2024

Conditions

Keywords

Blood flow restriction trainingChronic Obstructive Pulmonary Disease

Outcome Measures

Primary Outcomes (2)

  • Oxygen consumption (VO2)

    Oxygen consumption examined by cardiopulmonary exercise test

    Change from baseline (0 week) to follow up (20 weeks)

  • Diaphragm capacity

    Diaphragm capacity examined by diaphragmatic ultrasound

    Change from baseline (0 week) to follow up (20 weeks)

Secondary Outcomes (7)

  • Functional capacity

    Change from baseline (0 week) to follow up (20 weeks)

  • Heart Rate Variability

    Change from baseline (0 week) to follow up (20 weeks)

  • Pulmonary function test

    Change from baseline (0 week) to follow up (20 weeks)

  • Maximum respiratory pressure

    Change from baseline (0 week) to follow up (20 weeks)

  • Quality of life score (COPD-related questionnaire-I)

    Change from baseline (0 week) to follow up (20 weeks)

  • +2 more secondary outcomes

Study Arms (3)

Usual care group

ACTIVE COMPARATOR

The Usual care group will receive COPD and exercise-related education.

Behavioral: Disease and exercise suggestion

Aerobic exercise group-cycling

EXPERIMENTAL

The aerobic exercise group will receive cycling training intervention 2-3 times per week for 2 months.

Behavioral: Aerobic exercise intervention

BFR group-cycling + BFR

EXPERIMENTAL

The BFR group will receive cycling training combined with BFR intervention 2-3 times per week for 2 months.

Behavioral: Blood flow restriction (BFR) intervention

Interventions

The aerobic exercise intervention will utilize an ergometer. The program will be conducted 2-3 times per week over a 3-month period.

Aerobic exercise group-cycling

The participants will be provided by educational program about COPD self-care and home-based exercise approach.

Usual care group

Blood flow restriction (BFR) intervention will combine aerobic exercise on the ergometer with BFR training. The program will be conducted 2-3 times per week over a 3-month period.

BFR group-cycling + BFR

Eligibility Criteria

Age30 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • COPD classified as levels 2-4.
  • Stable condition without worsening in the past three months.
  • No participation in any rehabilitation program within the past six months.
  • Ability to understand and follow verbal commands and cooperate with an exercise training program.

You may not qualify if:

  • Unconscious or unable to cooperate with the evaluator.
  • Hospitalization due to acute illness within the past three months.
  • Severe joint diseases or history of lower limb surgery.
  • Severe cardiovascular disease (e.g., presence of a cardiac pacemaker or acute myocardial infarction within the past six months).
  • Dependence on oxygen supply.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Cheng Kung University Hostipal

Tainan, Taiwan, 701, Taiwan

RECRUITING

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

Methods

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Investigative Techniques

Study Officials

  • Kun-Ling Tsai, Ph.D.

    Department of Physical Therapy, National Cheng Kung University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Yu-Ting Huang, M.S.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor and Chair, Department of Physical Therapy

Study Record Dates

First Submitted

December 19, 2024

First Posted

January 3, 2025

Study Start

November 20, 2024

Primary Completion (Estimated)

December 31, 2028

Study Completion (Estimated)

December 31, 2030

Last Updated

January 3, 2025

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

IPD sharing plan will be decided after summarized data being published.

Locations